AmSurg receives 'hold' rating — 4 observations

Zacks analysts gave AmSurg a ranking of 3, indicting the company has a "hold" rating for the short term, according to Insider Trading Report.

Here are four observations:

1. In the short term, AmSurg shares are projected to reach $85.89.

2. Analysts predict the shares may hit a target price of $95 on the higher end and $64 on the lower end.

3. AmSurg shares are up nearly 17.8 percent in the last three-month period.

4. In the last four weeks, the shares rallied 0.53 percent.

More articles on surgery centers:
SCA receives 'sell' rating — 4 quick facts
Children's Hospital of Philadelphia opens Brandywine Valley Specialty Care and ASC: 5 things to know
10 new surgery centers in September 2015

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast